Growing from simple scanners to solutions that involve advanced informatics and systems, the field of nuclear medicine has evolved significantly over the past few years. Nuclear medicine is one such significant discovery. It uses radioactive materials (radiotracers) for observing bodily functions and for diagnosing and treating various diseases. These materials are generally inhaled, swallowed, or injected into the bloodstream. Doctors track the path of these materials with the help of specially designed cameras. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) scans are the two major imaging modalities in the nuclear medicine technology.
Browse full research report at: https://goo.gl/29Q7Ek
Recent Innovations in Nuclear Medicine
Value-based care has changed the way healthcare companies provide care delivery, thereby increasing the need for faster, user-friendly, and accurate imaging technologies. With molecular imaging doctors can make accurate decisions based on the particular cellular and molecular patterns of a disease.
Royal Philips recently launched their latest solutions and technologies that may drive the future of nuclear medicine.
- Vereos Digital PET/CT
It is the first ever fully digital PET/CT system. Incorporated with the company’s proprietary DPC tech, it can enable better characterization and detection of small lesions. The new digital PET/CT offers uncompromised quantification and detectability at just half the PET dose and also enables the detection of lesions in one tenth of the time.
Market Overview
Market Overview
Growing cases of various chronic diseases across the world are anticipated to augment growth of the global nuclear medicine market over the forecast period (from 2017 to 2021). Factors such as increased awareness, technological advancements, and abundance of radiotracers or radiopharmaceuticals are also estimated to fuel the demand over the years to come.
Moreover, need for precise and quick diagnostic processes and increased demand for advanced therapies are also projected to boost the global market. Some of the key companies in the worldwide market include Eckert & Ziegler Group; GE Healthcare; Bracco Imaging S.p.A.; Siemens Healthineers; and Toshiba Medical Systems Corp.
Request free sample @
No comments:
Post a Comment